|
|
|
|
|
|
|
|
|
|
Tuesday, April 20, 2010
Health Canada today released the April 2010 issue of the Canadian Adverse Reaction Newsletter (CARN).
This issue includes an article on leflunomide, a prescription drug used in the treatment of rheumatoid arthritis, and a suspected association with peripheral neuropathy (damage to sensory nerves, especially to hands and feet).
It also contains the annual adverse reaction and incident reporting statistics for 2009, as well as a quarterly summary of health professional and consumer advisories.
The April 2010 edition of CARN can be viewed on the Health Canada Web site.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.